VERONA PHARMA PLC
Institutional coverage
8 13F filers hold $VRNA.
13F holders
8
Insider buys · 90d
0
Congress · 90d
0
Smart Money · top-200 alpha cohort
No exposure this quarterNo top-200 alpha managers currently hold $VRNA. The institutional holders table below shows the broader 13F picture.
Institutional holders
Top 8 of 8 · Source: 13F-HR01
Summit Partners Public Asset Management, LLC
4.01% of portfolio
1,785,407 sh
02
TIG Advisors, LLC
4.08% of portfolio
635,267 sh
03
Cutter Capital Management, LP
4.42% of portfolio
160,000 sh
04
Rosalind Advisors, Inc.
3.77% of portfolio
100,000 sh
05
Velan Capital Investment Management LP
2.01% of portfolio
50,000 sh
06
Meteora Capital, LLC
0.55% of portfolio
40,000 sh
07
Westchester Capital Management, LLC
2.58% of portfolio
13,509 sh
08
Goldman Sachs
0.03% of portfolio
9,994 sh
Insider activity · last 90 days
No insider activity
No Form 4 filings on record for $VRNA in the recent window.
Congress trades · last 90 days
No Congress trades
No STOCK Act filings reference $VRNA in the recent window.
Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 08:19 UTC.